Page last updated: 2024-12-06

oxomemazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

oxomemazine: selective for M1 muscarinic receptors [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID19396
CHEMBL ID2104734
CHEBI ID135408
SCHEMBL ID423634
MeSH IDM0306120

Synonyms (86)

Synonym
AC-15943
oxomemazine
10h-phenothiazine-10-propanamine, n,n,.beta.-trimethyl-, 5,5-dioxide
3-(5,5-dioxido-10h-phenothiazin-10-yl)-n,n,2-trimethylpropan-1-amine
3689-50-7
10-(3-(dimethylamino)-2-methylpropyl)phenothiazine 5,5-dioxide
oxomemazina [inn-spanish]
oxomemazine [inn:dcf]
doxergan
phenothiazine, 10-(3-(dimethylamino)-2-methylpropyl)-, 5,5-dioxide
dioxo-9,9-(dimethylamino-3-methyl-2-propyl)-10-phenothiazine [french]
oxymemazine
dysedon
imakol
alimemazine s,s-dioxide
10-(3-(dimethylamino)-2-methylpropyl)phenothiazine-5,5-dioxide
oxomemazinum [inn-latin]
dosegran
brn 0289178
rp 6847
einecs 222-996-8
oxomemazine (inn)
doxergan (tn)
D07401
CHEBI:135408
3-(5,5-dioxophenothiazin-10-yl)-n,n,2-trimethylpropan-1-amine
NCGC00182075-02
NCGC00182075-03
CHEMBL2104734
6487-rp
oplex
rp-6847
6847-rp
exe-top
trimeprazine 5,5-dioxide
AKOS015962134
4-27-00-01270 (beilstein handbook reference)
oxomemazinum
oxomemazina
dioxo-9,9-(dimethylamino-3-methyl-2-propyl)-10-phenothiazine
6847 r.p.
unii-305mb38v1c
305mb38v1c ,
oxomemazin
oxomemazine [inn]
oxomemazine [mart.]
156576-01-1
oxomemazine [mi]
(+/-)-oxomemazine
oxomemazine [who-dd]
SCHEMBL423634
smr004701064
MLS006009989
3-(5,5-dioxido-10h-phenothiazin-10-yl)-n,n,2-trimethyl-1-propanamine #
QTQPVLDZQVPLGV-UHFFFAOYSA-N
6487 rp
6847 rp
phenothiazine, 10-[3-(dimethylamino)-2-methylpropyl]-, 5,5-dioxide
10-(3-(dimethylamino)-2-methylpropyl)-10h-phenothiazine 5,5-dioxide
FT-0698324
DTXSID5023405
unii-5gp9538p4s
10h-phenothiazine-10-propanamine, n,n,beta-trimethyl-, 5,5-dioxide, (-)-
10h-phenothiazine-10-propanamine, n,n,beta-trimethyl-, 5,5-dioxide, (+)-
unii-q824sgh3rn
SR-01000883964-1
sr-01000883964
(-)-oxomemazine
10h-phenothiazine-10-propanamine, n,n,.beta.-trimethyl-, 5,5-dioxide, (-)-
oxomemazine, (-)-
174508-13-5
oxomemazine, (+)-
10h-phenothiazine-10-propanamine, n,n,.beta.-trimethyl-, 5,5-dioxide, (+)-
5GP9538P4S ,
174508-14-6
Q824SGH3RN ,
(+)-oxomemazine
F20164
oxomemazine 1.0 mg/ml in methanol
trimeprazine sulphone; oxomemazine
Q3359071
mfcd00868197
DB13820
HY-136587
CS-0131898
MS-24971

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The proposed methods have been applied successfully for the analysis of the drug in pure form and in its dosage forms."( Extractive spectrophotometric methods for the determination of oxomemazine hydrochloride in bulk and pharmaceutical formulations using bromocresol green, bromocresol purple and bromophenol blue.
El-Didamony, AM, 2005
)
0.57
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phenothiazines
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Oxomemazine H1-Antihistamine Action87

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 80.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index80.17 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index133.90 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (80.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]